Last 12 months
Inside the activity.
1 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2023 Filed Feb 28, 2023 19:35 UTC |
Toussaint Claudia SSVP, CPSO
|
Tax withholdingCommon Stock | 287 | $102.55 | $29,431.85 |
DisclosureSEC source: 0001562180-23-002021 · primarydocument.xml · nonDerivative · entry 3 Toussaint Claudia S · CIK 0001421560 · SVP, CPSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,183 F3 · shares: Reflects units withheld to pay the tax liability incident to the vesting of restricted stock units granted on February 27, 2020 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). F4 · balance_after: Includes 35,482 shares held by the Claudia S. Toussaint Revocable Trust. Read SEC document |
| February 27, 2023 Filed Feb 28, 2023 19:35 UTC |
Toussaint Claudia SSVP, CPSO
|
Tax withholdingCommon Stock | 1,415 | $102.55 | $145,108.25 |
DisclosureSEC source: 0001562180-23-002021 · primarydocument.xml · nonDerivative · entry 2 Toussaint Claudia S · CIK 0001421560 · SVP, CPSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,470 F2 · shares: Reflects units withheld to pay the tax liability incident to the vesting of performance-based restricted stock units granted on February 27, 2020 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| February 27, 2023 Filed Feb 28, 2023 19:35 UTC |
Toussaint Claudia SSVP, CPSO
|
GrantCommon Stock | 4,546 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-002021 · primarydocument.xml · nonDerivative · entry 1 Toussaint Claudia S · CIK 0001421560 · SVP, CPSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,885 F1 · shares: Reflects shares of common stock earned upon vesting of performance-based restricted stock units granted February 27, 2020 upon achievement of performance criteria related to Total Shareholder Return. Read SEC document |
| February 27, 2023 Filed Feb 28, 2023 19:30 UTC |
Decker PatrickDirector · President & CEO
|
Tax withholdingCommon Stock | 3,199 | $102.55 | $328,057.45 |
DisclosureSEC source: 0001562180-23-002014 · primarydocument.xml · nonDerivative · entry 3 Decker Patrick · CIK 0001403434 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,393 F3 · shares: Reflects units withheld to pay the tax liability incident to the vesting of restricted stock units granted on February 27, 2020 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| February 27, 2023 Filed Feb 28, 2023 19:30 UTC |
Decker PatrickDirector · President & CEO
|
Tax withholdingCommon Stock | 13,902 | $102.55 | $1,425,650.10 |
DisclosureSEC source: 0001562180-23-002014 · primarydocument.xml · nonDerivative · entry 2 Decker Patrick · CIK 0001403434 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,592 F2 · shares: Reflects units withheld to pay the tax liability incident to the vesting of performance-based restricted stock units granted on February 27, 2020 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| February 27, 2023 Filed Feb 28, 2023 19:30 UTC |
Decker PatrickDirector · President & CEO
|
GrantCommon Stock | 30,313 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-002014 · primarydocument.xml · nonDerivative · entry 1 Decker Patrick · CIK 0001403434 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,494 F1 · shares: Reflects shares of common stock earned upon vesting of performance-based restricted stock units granted February 27, 2020 upon achievement of performance criteria related to Total Shareholder Return. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 00:31 UTC |
Yarkadas HayatiSVP & President, EU, WI & GLS
|
Tax withholdingCommon Stock | 64 | $102.55 | $6,563.20 |
DisclosureSEC source: 0001562180-23-002020 · primarydocument.xml · nonDerivative · entry 3 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,875 F3 · shares: Reflects units withheld to pay the tax liability incident to the vesting of restricted stock units granted on May 7, 2020 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 00:31 UTC |
Yarkadas HayatiSVP & President, EU, WI & GLS
|
Tax withholdingCommon Stock | 306 | $102.55 | $31,380.30 |
DisclosureSEC source: 0001562180-23-002020 · primarydocument.xml · nonDerivative · entry 2 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,939 F2 · shares: Reflects units withheld to pay the tax liability incident to the vesting of performance-based restricted stock units granted on May 7, 2020 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 00:31 UTC |
Yarkadas HayatiSVP & President, EU, WI & GLS
|
GrantCommon Stock | 5,772 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-002020 · primarydocument.xml · nonDerivative · entry 1 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,245 F1 · shares: Reflects shares of common stock earned upon vesting of performance-based restricted stock units granted May 7, 2020 upon achievement of performance criteria related to Total Shareholder Return. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 00:30 UTC |
McShane Geri-MichelleVP, Controller & CAO
|
Tax withholdingCommon Stock | 78 | $102.55 | $7,998.90 |
DisclosureSEC source: 0001562180-23-002017 · primarydocument.xml · nonDerivative · entry 3 McShane Geri-Michelle · CIK 0001769064 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,387 F4 · shares: Reflects units withheld to pay the tax liability incident to the vesting of restricted stock units granted on February 27, 2020 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 00:30 UTC |
McShane Geri-MichelleVP, Controller & CAO
|
Tax withholdingCommon Stock | 420 | $102.55 | $43,071.00 |
DisclosureSEC source: 0001562180-23-002017 · primarydocument.xml · nonDerivative · entry 2 McShane Geri-Michelle · CIK 0001769064 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,465 F3 · shares: Reflects units withheld to pay the tax liability incident to the vesting of performance-based restricted stock units granted on February 27, 2020 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 00:30 UTC |
McShane Geri-MichelleVP, Controller & CAO
|
GrantCommon Stock | 1,011 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-002017 · primarydocument.xml · nonDerivative · entry 1 McShane Geri-Michelle · CIK 0001769064 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,885 F1 · shares: Reflects shares of common stock earned upon vesting of performance-based restricted stock units granted February 27, 2020 upon achievement of performance criteria related to Total Shareholder Return. F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 00:30 UTC |
McGann Michael J.SVP & President Americas & MCS
|
Tax withholdingCommon Stock | 67 | $102.55 | $6,870.85 |
DisclosureSEC source: 0001562180-23-002016 · primarydocument.xml · nonDerivative · entry 3 McGann Michael J. · CIK 0001962070 · SVP & President Americas & MCS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,048 F3 · shares: Reflects units withheld to pay the tax liability incident to the vesting of restricted stock units granted on February 27, 2020 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 00:30 UTC |
McGann Michael J.SVP & President Americas & MCS
|
Tax withholdingCommon Stock | 386 | $102.55 | $39,584.30 |
DisclosureSEC source: 0001562180-23-002016 · primarydocument.xml · nonDerivative · entry 2 McGann Michael J. · CIK 0001962070 · SVP & President Americas & MCS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,115 F2 · shares: Reflects units withheld to pay the tax liability incident to the vesting of performance-based restricted stock units granted on February 27, 2020 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 00:30 UTC |
McGann Michael J.SVP & President Americas & MCS
|
GrantCommon Stock | 1,136 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-002016 · primarydocument.xml · nonDerivative · entry 1 McGann Michael J. · CIK 0001962070 · SVP & President Americas & MCS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,501 F1 · shares: Reflects shares of common stock earned upon vesting of performance-based restricted stock units granted February 27, 2020 upon achievement of performance criteria related to Total Shareholder Return. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 21:58 UTC |
Yarkadas HayatiSenior Vice President
|
SaleCommon Stock | 2,083 | $106.94 | $222,756.02 |
DisclosureSEC source: 0001562180-23-001517 · primarydocument.xml · nonDerivative · entry 1 Yarkadas Hayati · CIK 0001657363 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,473 Read SEC document |
| November 04, 2022 Filed Nov 8, 2022 16:53 UTC |
Pine Matthew FrancisSenior Vice President
|
SaleCommon Stock | 900 | $108.45 | $97,605.00 |
DisclosureSEC source: 0001209191-22-056118 · doc4.xml · nonDerivative · entry 3 Pine Matthew Francis · CIK 0001807057 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,819 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2022. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.39 to $109.3899, inclusive. The reporting person undertakes to provide to Xylem, Inc., any security holder of Xylem, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth in Footnote 5 to this Form 4. Read SEC document |
| November 04, 2022 Filed Nov 8, 2022 16:53 UTC |
Pine Matthew FrancisSenior Vice President
|
SaleCommon Stock | 3,382 | $107.76 | $364,444.32 |
DisclosureSEC source: 0001209191-22-056118 · doc4.xml · nonDerivative · entry 2 Pine Matthew Francis · CIK 0001807057 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,719 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.35 to $108.3499, inclusive. The reporting person undertakes to provide to Xylem, Inc., any security holder of Xylem, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth in Footnote 4 to this Form 4. Read SEC document |
| November 04, 2022 Filed Nov 8, 2022 16:53 UTC |
Pine Matthew FrancisSenior Vice President
|
SaleCommon Stock | 7,588 | $106.68 | $809,487.84 |
DisclosureSEC source: 0001209191-22-056118 · doc4.xml · nonDerivative · entry 1 Pine Matthew Francis · CIK 0001807057 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,101 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.33 to $107.3299, inclusive. The reporting person undertakes to provide to Xylem, Inc., any security holder of Xylem, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth in Footnote 2 to this Form 4. F3 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| November 04, 2022 Filed Dec 1, 2022 21:54 UTC |
Flinton DavidSenior Vice President
|
Tax withholdingCommon Stock | 373 | $107.21 | $39,989.33 |
DisclosureSEC source: 0001209191-22-059208 · doc4.xml · nonDerivative · entry 1 Flinton David · CIK 0001654800 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,233 F1 · shares: Reflects the withholding of common stock to pay the tax liability incident to the vesting of restricted stock units granted on November 4, 2019, under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated as of February 24, 2016). F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| September 06, 2022 Filed Sep 8, 2022 14:43 UTC |
Toussaint Claudia SSenior Vice President
|
SaleCommon Stock | 16,825 | $91.37 | $1,537,264.92 |
DisclosureSEC source: 0001209191-22-049130 · doc4.xml · nonDerivative · entry 1 Toussaint Claudia S · CIK 0001421560 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,786 F1 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 16,525 Shares were executed at a range of prices from $90.97 to $91.9699. 300 Shares were executed at a range of prices from $92.07 to $93.0699.The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. F2 · price: Includes additional shares due to dividend reinvestment. F3 · price: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on August 4, 2022. Read SEC document |
| August 10, 2022 Filed Aug 11, 2022 20:27 UTC |
Harker Victoria DDirector
|
SaleCommon Stock | 5,000 | $100.26 | $501,287.00 |
DisclosureSEC source: 0001209191-22-045423 · doc4.xml · nonDerivative · entry 1 Harker Victoria D · CIK 0001350579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,099 F1 · price: This price represents the weighted average price per Share of the Issuer. Shares were sold at prices ranging from $100.2571 to $100.2700. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price Read SEC document |
| August 04, 2022 Filed Aug 5, 2022 15:34 UTC |
Beliveau-Dunn JeanneDirector
|
SaleCommon Stock | 600 | $96.65 | $57,990.00 |
DisclosureSEC source: 0001209191-22-044502 · doc4.xml · nonDerivative · entry 1 Beliveau-Dunn Jeanne · CIK 0001714894 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,553 F1 · balance_after: Includes additional shares due to Dividend Reinvestment. F2 · balance_after: These options were exercised and sold pursuant to the Reporting Person's 10b5-1 Plan. Read SEC document |
| June 27, 2022 Filed Jun 29, 2022 20:04 UTC |
Yarkadas HayatiSenior Vice President
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,898 | $0.00 Strike: $63.55 | $0.00 |
DisclosureSEC source: 0001209191-22-039773 · doc4.xml · derivative · entry 3 Yarkadas Hayati · CIK 0001657363 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,076 Underlying: Common Stock · 5,898 shares Expires 2030-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The May 7, 2020 option grant vests in one third increments on February 27, 2021, February 27, 2022 and February 27, 2023. Read SEC document |
| June 27, 2022 Filed Jun 29, 2022 20:04 UTC |
Yarkadas HayatiSenior Vice President
|
SaleCommon Stock | 5,898 | $80.06 | $472,212.16 |
DisclosureSEC source: 0001209191-22-039773 · doc4.xml · nonDerivative · entry 2 Yarkadas Hayati · CIK 0001657363 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,556 F1 · shares: The exercise and sale was made pursuant to a 10b5-1 plan adopted by the reporting person on May 19, 2022. F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). Shares were sold at a range of prices from $80.00 to $80.31. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price Read SEC document |
| June 27, 2022 Filed Jun 29, 2022 20:04 UTC |
Yarkadas HayatiSenior Vice President
|
Exercise / conversionCommon Stock | 5,898 | $63.55 | $374,817.90 |
DisclosureSEC source: 0001209191-22-039773 · doc4.xml · nonDerivative · entry 1 Yarkadas Hayati · CIK 0001657363 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,454 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The exercise and sale was made pursuant to a 10b5-1 plan adopted by the reporting person on May 19, 2022. Read SEC document |
| June 21, 2022 Filed Jun 22, 2022 20:06 UTC |
Yarkadas HayatiSenior Vice President
|
SaleCommon Stock | 2,082 | $74.18 | $154,436.10 |
DisclosureSEC source: 0001209191-22-038668 · doc4.xml · nonDerivative · entry 1 Yarkadas Hayati · CIK 0001657363 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,556 F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on May 19, 2022. F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,600 shares were sold at a range of prices from $73.78 to $74.62. 482 shares were sold at a range of prices from $74.80 to $74.84. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price Read SEC document |
| June 14, 2022 Filed Jun 14, 2022 16:14 UTC |
Cerwinka FranzSVP and President, Emerging Ma
|
SaleCommon Stock | 925 | $75.79 | $70,105.84 |
DisclosureSEC source: 0001209191-22-036662 · doc4.xml · nonDerivative · entry 1 Cerwinka Franz · CIK 0001813828 · SVP and President, Emerging Ma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,688 F1 · shares: Reflects the sale of common stock to pay the tax liability incident to the vesting of restricted stock units granted on June 12, 2020 under the Xylem 2011 Omnibus Incentive Plan. F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. F3 · balance_after: Amount shown reflects additional shares acquired via a dividend reinvestment plan or DRIP. Read SEC document |
| May 12, 2022 Filed May 16, 2022 19:00 UTC |
TAMBAKERAS MARKOS IDirector
|
GrantCommon Stock | 1,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-029346 · doc4.xml · nonDerivative · entry 1 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,140 F1 · shares: Reflects the award of restricted stock units which are scheduled to vest the day before the 2023 Annual Shareowner Meeting. Read SEC document |
| May 12, 2022 Filed May 16, 2022 23:01 UTC |
Tretikov LilaDirector
|
GrantCommon Stock | 1,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-029349 · doc4.xml · nonDerivative · entry 1 Tretikov Lila · CIK 0001620654 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,553 F1 · shares: Reflects the issuance of an RSU award which is scheduled to vest the day before the 2023 Annual Shareowner Meeting F2 · balance_after: Amount shown reflects additional shares acquired via a dividend reinvestment plan or DRIP. Read SEC document |
| May 12, 2022 Filed May 16, 2022 22:58 UTC |
Peribere Jerome ADirector
|
GrantCommon Stock | 1,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-029343 · doc4.xml · nonDerivative · entry 1 Peribere Jerome A · CIK 0001484527 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,812 F1 · shares: Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2023 annual shareholders' meeting. Read SEC document |
| May 12, 2022 Filed May 16, 2022 23:03 UTC |
Yadav UdayDirector
|
GrantCommon Stock | 1,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-029351 · doc4.xml · nonDerivative · entry 1 Yadav Uday · CIK 0001479938 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,541 F1 · shares: Reflects the issuance of an RSU award which is scheduled to vest the day before the 2023 Annual Shareowner Meeting Read SEC document |
| May 12, 2022 Filed May 16, 2022 22:54 UTC |
Morelli Mark DDirector
|
GrantCommon Stock | 1,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-029338 · doc4.xml · nonDerivative · entry 1 Morelli Mark D · CIK 0001411290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,232 F1 · shares: Reflects the award of restricted stock units. The Reporting Person elected to defer the vesting of the RSU Award until Separation from Service. F2 · balance_after: Includes RSUs which the reporting person elected to defer the vesting of the award until Separation from Service. Read SEC document |
| May 12, 2022 Filed May 16, 2022 22:53 UTC |
Harker Victoria DDirector
|
GrantCommon Stock | 1,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-029336 · doc4.xml · nonDerivative · entry 1 Harker Victoria D · CIK 0001350579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,099 F1 · shares: Reflects the issuance of an RSU award which is scheduled to vest the day before the 2023 Annual Shareowner Meeting Read SEC document |
| May 12, 2022 Filed May 16, 2022 22:50 UTC |
FRIEL ROBERT FDirector
|
GrantCommon Stock | 2,627 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-029335 · doc4.xml · nonDerivative · entry 1 FRIEL ROBERT F · CIK 0001224110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,538 F1 · shares: Reflects the award of restricted stock units. The Reporting Person elected to defer the vesting of the RSU Award until Separation from Service. F2 · balance_after: Amount shown reflects additional shares acquired via a dividend reinvestment plan or DRIP. Read SEC document |
| May 12, 2022 Filed May 16, 2022 22:45 UTC |
LORANGER STEVEN RDirector
|
GrantCommon Stock | 1,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-029334 · doc4.xml · nonDerivative · entry 1 LORANGER STEVEN R · CIK 0001226924 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,238 F1 · shares: Reflects the award of restricted stock units. The Reporting Person elected to defer the vesting of the RSU Award until Separation from Service. F2 · balance_after: Includes RSUs which the reporting person elected to defer the vesting of the award until Separation from Service. Read SEC document |
| May 12, 2022 Filed May 16, 2022 22:35 UTC |
Beliveau-Dunn JeanneDirector
|
GrantCommon Stock | 1,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-029330 · doc4.xml · nonDerivative · entry 1 Beliveau-Dunn Jeanne · CIK 0001714894 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,150 F1 · shares: Reflects the issuance of an RSU award which is scheduled to vest the day before the 2023 Annual Shareowner Meeting F2 · balance_after: Amount shown reflects additional shares acquired via a dividend reinvestment plan or DRIP. Read SEC document |
| May 09, 2022 Filed May 10, 2022 17:42 UTC |
Pine Matthew FrancisSenior Vice President
|
Tax withholdingCommon Stock | 5,511 | $84.98 | $468,324.78 |
DisclosureSEC source: 0001209191-22-028119 · doc4.xml · nonDerivative · entry 1 Pine Matthew Francis · CIK 0001807057 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,608 F1 · shares: Reflects the withholding of common stock to pay the tax liability incident to the vesting of restricted stock units granted on May 7, 2020 under the Xylem 2011 Omnibus Incentive Plan Read SEC document |
| May 09, 2022 Filed May 10, 2022 21:45 UTC |
Yarkadas HayatiSenior Vice President
|
SaleCommon Stock | 75 | $86.37 | $6,477.75 |
DisclosureSEC source: 0001209191-22-028122 · doc4.xml · nonDerivative · entry 1 Yarkadas Hayati · CIK 0001657363 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,638 F1 · shares: Reflects the sale of common stock to pay the tax liability incident to the vesting of restricted stock units granted on May 7, 2020 under the Xylem 2011 Omnibus Incentive Plan F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price Read SEC document |
| April 18, 2022 Filed Apr 19, 2022 20:00 UTC |
Sabol Colin RSenior Vice President
|
SaleCommon Stock | 4,233 | $83.05 | $351,537.95 |
DisclosureSEC source: 0001209191-22-024744 · doc4.xml · nonDerivative · entry 1 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,373 F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on March 16, 2022. F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 2,633 Shares were executed at a range of prices from $82.26 to $83.17. 1,600 Shares were executed at a range of prices from $83.39 to $84.21. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| March 02, 2022 Filed Mar 3, 2022 16:42 UTC |
Cerwinka FranzSVP and President, Emerging Ma
|
SaleCommon Stock | 157 | $87.84 | $13,791.16 |
DisclosureSEC source: 0001209191-22-015496 · doc4.xml · nonDerivative · entry 1 Cerwinka Franz · CIK 0001813828 · SVP and President, Emerging Ma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,738 F1 · shares: Reflects the sale of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price Read SEC document |
| March 02, 2022 Filed Mar 3, 2022 22:03 UTC |
Yarkadas HayatiSenior Vice President
|
SaleCommon Stock | 43 | $87.87 | $3,778.41 |
DisclosureSEC source: 0001209191-22-015605 · doc4.xml · nonDerivative · entry 1 Yarkadas Hayati · CIK 0001657363 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,255 F1 · shares: Reflects the sale of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 16:04 UTC |
Cerwinka FranzSVP and President, Emerging Ma
|
SaleCommon Stock | 292 | $86.50 | $25,256.69 |
DisclosureSEC source: 0001209191-22-014671 · doc4.xml · nonDerivative · entry 1 Cerwinka Franz · CIK 0001813828 · SVP and President, Emerging Ma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,895 F1 · shares: Reflects the sale of common stock to pay the tax liability incident to the vesting of restricted stock units granted on June 12, 2020 under the Xylem 2011 Omnibus Incentive Plan F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 21:18 UTC |
Yarkadas HayatiSenior Vice President
|
SaleCommon Stock | 71 | $86.61 | $6,149.64 |
DisclosureSEC source: 0001209191-22-014719 · doc4.xml · nonDerivative · entry 1 Yarkadas Hayati · CIK 0001657363 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,298 F1 · shares: Reflects the sale of common stock to pay the tax liability incident to the vesting of restricted stock units granted on May 7, 2020 under the Xylem 2011 Omnibus Incentive Plan F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 16:42 UTC |
Cerwinka FranzSVP and President, Emerging Ma
|
GrantStock Option (Right to Buy) · Derivative | 8,182 | $0.00 Strike: $86.76 | $0.00 |
DisclosureSEC source: 0001209191-22-015496 · doc4.xml · derivative · entry 3 Cerwinka Franz · CIK 0001813828 · SVP and President, Emerging Ma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,182 Underlying: Common · 8,182 shares Expires 2031-03-01 F4 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan, that are scheduled to vest in one third increments on March 1, 2023, March 1, 2024 and March 1, 2025. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 16:42 UTC |
Cerwinka FranzSVP and President, Emerging Ma
|
GrantCommon Stock | 1,873 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015496 · doc4.xml · nonDerivative · entry 2 Cerwinka Franz · CIK 0001813828 · SVP and President, Emerging Ma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,611 F3 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan, that are scheduled to vest in one third increments on March 1, 2023, March 1, 2024 and March 1, 2025. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 16:52 UTC |
Pine Matthew FrancisSenior Vice President
|
GrantStock Option (Right to Buy) · Derivative | 15,106 | $0.00 Strike: $86.76 | $0.00 |
DisclosureSEC source: 0001209191-22-015552 · doc4.xml · derivative · entry 3 Pine Matthew Francis · CIK 0001807057 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,106 Underlying: Common · 15,106 shares Expires 2032-03-01 F3 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan that are scheduled to vest in one third increments on March 1, 2023, March 1, 2024 and March 1, 2025. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 16:52 UTC |
Pine Matthew FrancisSenior Vice President
|
GrantCommon Stock | 3,458 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015552 · doc4.xml · nonDerivative · entry 2 Pine Matthew Francis · CIK 0001807057 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,119 F2 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan which are scheduled to vest in one third increments on March 1, 2023, March 1, 2024 and March 1, 2025 Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 16:52 UTC |
Pine Matthew FrancisSenior Vice President
|
Tax withholdingCommon Stock | 217 | $86.76 | $18,826.92 |
DisclosureSEC source: 0001209191-22-015552 · doc4.xml · nonDerivative · entry 1 Pine Matthew Francis · CIK 0001807057 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,661 F1 · shares: Reflects the withholding of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:54 UTC |
Rowland Sandra E.Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 21,400 | $0.00 Strike: $86.76 | $0.00 |
DisclosureSEC source: 0001209191-22-015562 · doc4.xml · derivative · entry 3 Rowland Sandra E. · CIK 0001629360 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,400 Underlying: Common · 21,400 shares Expires 2032-03-01 F3 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan that are scheduled to vest in one third increments on March 1, 2023, March 1, 2024 and March 1, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.